Results 151 to 160 of about 251,532 (186)
Some of the next articles are maybe not open access.

Etanercept in Juvenile Rheumatoid Arthritis

The Annals of Pharmacotherapy, 2001
OBJECTIVE: To review the classification, pathophysiology, safety, and efficacy of treatment options for juvenile rheumatoid arthritis (JRA). Etanercept, the agent most recently approved by the Food and Drug Administration for use in JRA, is featured. DATA SOURCES: Articles were identified from a search of the MEDLINE database (1966 to January 2000) and
C J, Johnson, K M, Reilly, K M, Murray
openaire   +2 more sources

Juvenile rheumatoid arthritis—assessment

The Indian Journal of Pediatrics, 1996
The assessment of overall health status of a child with juvenile rheumatoid arthritis (JRA) is complex and multi-dimensional. The general physical examination is complemented by a rheumatological evaluation that includes determination of articular indices of inflammation and duration of inactivity stiffness.
T B, Graham, E H, Giannini
openaire   +2 more sources

IS IT JUVENILE RHEUMATOID ARTHRITIS OR FIBROMYALGIA

Medical Clinics of North America, 2000
For the clinician evaluating adolescents with chronic musculoskeletal pain and fatigue, the distinctions between JRA and FS are clear based on physical examination findings. The two conditions can coexist. For the patient with an initial diagnosis of either JRA or FS whose clinical response to therapy is not in keeping with expectations or physical ...
openaire   +2 more sources

The Immunogenetics of Juvenile Rheumatoid Arthritis

Rheumatic Disease Clinics of North America, 1991
Recent major advances in understanding the genetic structure of the human leukocyte antigen (HLA) region and how HLA molecules contribute to immune responses have been paralleled by more precise identification of specific HLA genes conferring susceptibility to the various forms of juvenile rheumatoid arthritis (JRA).
openaire   +2 more sources

Mycoplasma in Juvenile Rheumatoid Arthritis

Acta Rheumatologica Scandinavica, 1971
SummaryTwo cases of juvenile rheumatoid arthritis (JRA) with a positive mycoplasma isolation from synovial fluid are presented. The second patient, who was seen when the disease was in an early stage, had antibodies against an isolate from RA and also a T-strain mycoplasma from nongonococcal urethritis.
E, Jansson   +3 more
openaire   +2 more sources

Treatment of juvenile rheumatoid arthritis

Current Opinion in Rheumatology, 1993
New information on the treatment of juvenile rheumatoid arthritis emphasizes more aggressive control of arthritis, particularly the use of methotrexate, both in low- and higher-dose regimens. Information concerning drug toxicity, including that of the nonsteroidal anti-inflammatory drugs, second-line agents, and methotrexate, suggests that these drugs ...
openaire   +2 more sources

HYPOHISTIDINEMIA IN JUVENILE RHEUMATOID ARTHRITIS

Acta Paediatrica, 1976
ABSTRACT. The mean level of plasma histidine in 86 children with rheumatoid arthritis was found to be significantly lower in comparison with that of controls. The possible influence of various drugs on the plasma histidine concentration is discussed.
W, Endres, K, Birkmeier, E, Stoeber
openaire   +2 more sources

Aspirin in Juvenile Rheumatoid Arthritis

Archives of Pediatrics & Adolescent Medicine, 1985
How does the rheumatologist respond to the report by Remington et al 1 of three patients with Reye syndrome who were treated with aspirin for juvenile rheumatoid arthritis? It is not an easy matter. Although juvenile rheumatoid arthritis is an infrequent disease and Reye syndrome is an unusual complication of salicylate therapy and viral disease, it ...
openaire   +2 more sources

Pharmacotherapy of Juvenile Rheumatoid Arthritis

Pediatric Clinics of North America, 1981
Salicylate is the drug of first choice in the initial treatment of juvenile rheumatoid arthritis. In therapeutic dosage it will adequately control joint symptoms in the majority of patients. For children who do not respond to or are intolerant of salicylate, a change to one of the other nonsteroidal anti-inflammatory agents is appropriate.
openaire   +2 more sources

Juvenile Rheumatoid Arthritis

Clinics in Rheumatic Diseases, 1983
E J, Brewer, E H, Giannini
openaire   +2 more sources

Home - About - Disclaimer - Privacy